{"id":182730,"date":"2026-01-29T12:39:00","date_gmt":"2026-01-29T17:39:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/01\/29\/venkatraman-radhakrishnan-an-artificial-intelligence-tool-for-predicting-relapse-in-children-with-all\/"},"modified":"2026-01-29T13:25:09","modified_gmt":"2026-01-29T18:25:09","slug":"venkatraman-radhakrishnan-an-artificial-intelligence-tool-for-predicting-relapse-in-children-with-all","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/01\/29\/venkatraman-radhakrishnan-an-artificial-intelligence-tool-for-predicting-relapse-in-children-with-all\/","title":{"rendered":"Venkatraman Radhakrishnan: An Artificial Intelligence Tool for Predicting Relapse in Children With ALL"},"content":{"rendered":"<p><a href=\"https:\/\/oncodaily.com\/voices\/venkatraman-radhakrishnan-448731\">Venkatraman Radhakrishnan: An Artificial Intelligence Tool for Predicting Relapse in Children With ALL<\/a><\/p>\n<p><a href=\"https:\/\/oncodaily.com\/voices\/venkatraman-radhakrishnan-448731\">https:\/\/oncodaily.com\/voices\/venkatraman-radhakrishnan-448731<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-01-29 12:39:00<\/a><\/p>\n<p>Source Domain: <a href=\"oncodaily.com\">oncodaily.com<\/a><\/p>\n<p>Here\u2019s a summary of the article using an unordered list with 6 key points:<\/p>\n<ul>\n<li>\n<p><strong>Title and Authors<\/strong>: The article titled <strong>&#8220;PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia&#8221;<\/strong> lists numerous authors, including Venkatraman Radhakrishnan.<\/p>\n<\/li>\n<li>\n<p><strong>Key Insight<\/strong>: The primary insight is that <strong>the use of Artificial Intelligence (AI) is more effective than traditional clinician practices in predicting relapse in Pediatric Acute Lymphoblastic Leukaemia (ALL)<\/strong>.<\/p>\n<\/li>\n<li>\n<p><strong>Study Details<\/strong>: This AI tool was tested in the <strong>ICICLE pre trial cohort<\/strong>.<\/p>\n<\/li>\n<li>\n<p><strong>AI Performance<\/strong>: The AI tool developed under the project, <em>PREPARE ALL<\/em>, performed better than clinicians in predicting outcomes for children with acute lymphoblastic leukaemia.<\/p>\n<\/li>\n<li>\n<p><strong>Contribution of Venkatraman Radhakrishnan<\/strong>: Venkatraman Radhakrishnan was a co-author on the study, emphasizing his active role in advancing research in this field.<\/p>\n<\/li>\n<li>\n<p><strong>Publication<\/strong>: The findings and details of the project were shared and discussed by JCO Clinical Cancer Informatics and highlighted in a post on X by Venky (Consultant at Cancer Institute, Adyar).<\/p>\n<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Venkatraman Radhakrishnan: An Artificial Intelligence Tool for Predicting Relapse in Children With ALL https:\/\/oncodaily.com\/voices\/venkatraman-radhakrishnan-448731 Publish&#8230;<\/p>\n","protected":false},"author":1,"featured_media":182731,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/oncodaily.com\/pub\/uploads\/2026\/01\/Venkatraman-Radhakrishnan-1.webp","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[20],"class_list":["post-182730","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","tag-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/182730"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=182730"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/182730\/revisions"}],"predecessor-version":[{"id":182732,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/182730\/revisions\/182732"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/182731"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=182730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=182730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=182730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}